Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Monica M. Bertagnolli(National Institutes of Health), Ernest T. Hawk(The University of Texas MD Anderson Cancer Center), Janet Wittes(Deloitte (United States)), G. Mabel Woloj(Pfizer (United States)), John Burn(Newcastle University), Donya Bagheri(CCS Associates (United States)), T. Raymond Foley(Lancaster General Hospital), Ann G. Zauber(Memorial Sloan Kettering Cancer Center), Scott D. Solomon(Brigham and Women's Hospital), Finlay Macrae(The Royal Melbourne Hospital), Donald K. Corle(National Cancer Institute), Rebecca B. Rosenstein(Pfizer (United States)), Jaye L. Viner(Memorial Sloan Kettering Cancer Center), Thomas Sylwestrowicz(University of Saskatchewan), Thomas Dewar(Texas Health Harris Methodist Hospital Fort Worth), John R. Saltzman(Brigham and Women's Hospital), Jie Tang(Bengbu Medical College), Daniel C. Chung(Massachusetts General Hospital), Mark Redston(Brigham and Women's Hospital), Frédéric Boisserie(Pfizer (United States)), Timothy Hess(University of Wisconsin–Madison), Craig Eagle(Pfizer (United States)), Gary Gordon, KyungMann Kim(University of Wisconsin–Madison), Ronald E. Pruitt(Nashville Medical Research Institute), Bruce Salzberg(Atlanta Gastroenterology Associates), Neville E. Hoffman(Sir Charles Gairdner Hospital), William F. Anderson(Agricultural Research Service)
Cited by 1,041
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k